Mölndal, Sweden

Bengt Andersson

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 98(Granted Patents)


Location History:

  • 20 Sjuntorp, SE (1984)
  • Molndal, SE (2014)
  • Mölndal, SE (2015 - 2020)

Company Filing History:


Years Active: 1984-2020

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Bengt Andersson

Introduction

Bengt Andersson, a notable inventor based in Mölndal, Sweden, has made significant contributions to the field of biomedical innovations. With an impressive portfolio of 11 patents, he has demonstrated his expertise in developing advanced medical techniques and treatments. His research primarily focuses on methods involving T-cell priming and dendritic cell production, addressing critical challenges in immunotherapy.

Latest Patents

Among his latest patents, the method for co-differentiation of monocytes from allogeneic donors stands out. This invention presents a novel method for producing non-exhausted immature dendritic cells (DCs) from allogeneic leukocytes sourced from at least two different donors. By isolating monocytes from this mixture, the method facilitates the generation of viable DCs necessary for various therapeutic applications.

Additionally, his patent concerning the in vitro method for priming T cells is noteworthy. This invention is crucial for developing treatments suitable for patients suffering from viral infections, offering promising avenues for enhancing patient care and outcomes.

Career Highlights

Throughout his career, Bengt Andersson has worked with distinguished companies, including Immunicum AB, where he further honed his skills in the realm of immunotherapy and innovative medical solutions. His dedication to research and innovation has paved the way for advancements that significantly impact healthcare.

Collaborations

Bengt has collaborated with various esteemed colleagues, including Alex Karlsson-Parra and Anna-Carin Wallgren. These partnerships have fostered an environment of innovation, allowing the team to explore and develop groundbreaking solutions in the biomedical field.

Conclusion

In conclusion, Bengt Andersson's contributions to the field of biomedical innovations through his patents and collaborative efforts highlight his commitment to improving patient outcomes and advancing medical technology. His work serves as an inspiration for future inventors and researchers dedicated to making a difference in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…